 effect hmg-coa reductas inhibitor hypercholesterolem patient hemodialysi efficaci lovastatin simvastatin competit inhibitor glutaryl reductas hemodialysi HD patient hypercholesterolemia moder hypertriglyceridemia select patient requir screen hemodialysi patient four-week placebo period lovastatin simvastatin group patient dose period month thirty-six patient studi lovastatin month mg month mg simvastatin month mg month mg month mg total serum cholesterol mg/dl ldl cholesterol mg/dl apolipoprotein mg/dl ratio ldl apo b/ldl cholesterol remark effect reduct cholesterol concentr vldl lovastatin mg/dl simvastatin ratio triglycerides/cholesterol vldl vldl format poor cholesterol rich triglycerid